Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Jae-Yoon Jeon"'
Publikováno v:
Maxillofacial Plastic and Reconstructive Surgery, Vol 41, Iss 1, Pp 1-5 (2019)
Abstract Background Brain abscess is a life-threatening condition that occurs due to complications during a neurosurgical procedure, direct cranial trauma, or the presence of local or distal infection. Infection in the oral cavity can also be conside
Externí odkaz:
https://doaj.org/article/7e1497ef1fb1411ea0bd6f1fcb7dce1f
Publikováno v:
Maxillofacial Plastic and Reconstructive Surgery, Vol 41, Iss 1, Pp 1-1 (2019)
In the original publication of this article [1], the author wanted to correct the ‘XXX University Hospital’ in below two sentences. The ‘XXX University Hospital’ should be the ‘Hanyang University Hospital’.
Externí odkaz:
https://doaj.org/article/2dfe587c5fd24138ad505cd864b8eb1c
Autor:
Megan E. Zavorka Thomas, Navjot Pabla, Daelynn R. Buelow, Sharyn D. Baker, Alex Sparreboom, Jae Yoon Jeon, Josie A. Silvaroli, Moray J. Campbell, Zahra Talebi
Publikováno v:
Blood Advances. 5:5041-5046
Drug resistance and relapse are common challenges in acute myeloid leukemia (AML), particularly in an aggressive subset bearing internal tandem duplications (ITDs) of the FLT3 receptor (FLT3-ITD+). The tyrosine kinase inhibitor gilteritinib is approv
Autor:
Eric D. Eisenmann, Jack C. Stromatt, Sydney Fobare, Kevin M. Huang, Daelynn R. Buelow, Shelley Orwick, Jae Yoon Jeon, Robert H. Weber, Bill Larsen, Alice S. Mims, Erin Hertlein, John C. Byrd, Sharyn D. Baker
Publikováno v:
Cancers; Volume 15; Issue 1; Pages: 29
Acute myeloid leukemia (AML) with mutations in the tumor suppressor gene TP53 confers a dismal prognosis with 3-year overall survival of
Autor:
Jae Yoon Jeon, Alice A. Gibson, Alex Sparreboom, Xiyuan Lu, Alessia Lodi, Julie Nguyen, Sharyn D. Baker, Meghan Collins, Douglas H. Sweet, Zahra Talebi, Muhammad Erfan Uddin, Daelynn R. Buelow, Rosa Lapalombella, Shannon R. Sweeney, Moray J. Campbell, Stefano Tiziani, Megan E. Zavorka Thomas, Lindsey T. Brinton
Publikováno v:
Molecular Cancer Therapeutics. 20:2207-2217
Acute myeloid leukemia (AML) with an FLT3 internal tandem duplication (FLT3-ITD) mutation is an aggressive hematologic malignancy associated with frequent relapse and poor overall survival. The tyrosine kinase inhibitor gilteritinib is approved for t
Autor:
Daelynn R. Buelow, Bhavana Bhatnagar, Shelley J. Orwick, Jae Yoon Jeon, Eric D. Eisenmann, Jack C. Stromatt, Navjot Singh Pabla, James S. Blachly, Sharyn D. Baker, Bradley W. Blaser
Publikováno v:
Blood advances. 6(17)
Despite the clinical benefit associated with gilteritinib in relapsed/refractory acute myeloid leukemia (AML), most patients eventually develop resistance through unknown mechanisms. To delineate the mechanistic basis of resistance to gilteritinib, w
Publikováno v:
Pharmaceutical research. 39(8)
The approval of four small interfering RNA (siRNA) products in the past few years has demonstrated unequivocally the therapeutic potential of this novel modality. Three such products (givosiran, lumasiran and inclisiran) are liver-targeted, using tri
Autor:
Kevin M. Huang, Erin Hertlein, Bill Larsen, Robert J. Weber, Daelynn R. Buelow, John C. Byrd, Josie A. Silvaroli, Sharyn D. Baker, Shelley Orwick, Eric D. Eisenmann, Sydney Fobare, Jae Yoon Jeon, Jack Stromatt
Publikováno v:
The FASEB Journal. 35
Autor:
Jeffrey E. Rubnitz, Anang A. Shelat, Daelynn R. Buelow, Shelley Orwick, Tanja A. Gruber, Marissa S. Pioso, Shuiying Hu, Mengyu Li, Hiroto Inaba, Qiang Fu, Christina D. Drenberg, Sharyn D. Baker, Raul C. Ribeiro, Jinjun Dang, R. Kiplin Guy, Anitria Cotton, Jae Yoon Jeon
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-16 (2019)
Nature Communications
Nature Communications
Improvement in survival has been achieved for children and adolescents with AML but is largely attributed to enhanced supportive care as opposed to the development of better treatment regimens. High risk subtypes continue to have poor outcomes with e
Autor:
Megan E, Zavorka Thomas, Xiyuan, Lu, Zahra, Talebi, Jae Yoon, Jeon, Daelynn R, Buelow, Alice A, Gibson, Muhammad Erfan, Uddin, Lindsey T, Brinton, Julie, Nguyen, Meghan, Collins, Alessia, Lodi, Shannon R, Sweeney, Moray J, Campbell, Douglas H, Sweet, Alex, Sparreboom, Rosa, Lapalombella, Stefano, Tiziani, Sharyn D, Baker
Publikováno v:
Mol Cancer Ther
Acute myeloid leukemia (AML) with a FLT3 internal tandem duplication (FLT3-ITD) mutation is an aggressive hematologic malignancy associated with frequent relapse and poor overall survival. The tyrosine kinase inhibitor gilteritinib is approved for th